Back to search

Article

Systemic drivers and molecular mechanisms of sarcopenia in aetiology-specific end-stage liver disease

2025-08-25

Abstract excerpt

<h4>Introduction</h4> Patients with end-stage liver disease (ESLD) often present with sarcopenia, defined as loss of skeletal muscle mass and quality, which is associated with reduced quality of life and increased mortality. However, the molecular mechanisms driving sarcopenia in ESLD are not fully understood and there are currently no therapeutic interventions. This study aimed to identify potential circulating...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2feb0c5b-49a2-5567-9f9e-8cd1c58d2a87
DOI
10.1101/2025.08.21.671433
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systemic drivers and molecular mechanisms of sarcopenia in aetiology-specific end-stage liver diseaseDOI 10.1101/2025.08.21.671433
Select a neighboring publication to make it the new centre.